Sponsored by The Journal of Physiology
The role of the vagus in controlling cardiac function is essential. Loss of heart rate variability of sinus arrhythmia is a prognostic indicator of cardiac disease including heart failure, arrhythmias and sudden cardiac death. What drives the vagus and how its influence is so important in maintaining a healthy heart is not known. This symposium comes at a time when chronic stimulation of the vagus nerve is being trialled as a therapeutic treatment in human patients with heart failure. Speakers will present state-of-the-art findings into novel ways of targeting the cardiac vagus and the potential therapeutics outcomes.
Organisers:
David Paterson
University of Oxford
United Kingdom
University of Oxford
United Kingdom
Alona Ben-Tal
Massey University
New Zealand
Massey University
New Zealand
Speakers:
Systems medicine of neurogenic hypertension
14.15 - 14.45
14.15 - 14.45
James Schwaber
Thomas Jefferson University
United States
Thomas Jefferson University
United States
Peptide modulation of cardiac autonomic transmission
14.45 - 15.00
14.45 - 15.00
Neil Herring
University of Oxford
United Kingdom
University of Oxford
United Kingdom
The evolving role of vagal activity and its potential in clinical management
15.00 - 15.30
15.00 - 15.30
Maria Teresa La Rovere
Istituto Scientifico di Montescano
Italy
Istituto Scientifico di Montescano
Italy
Novel insights into cardiac vagal ganglion transmission in situ
15.30 - 15.45
15.30 - 15.45
Lauren Salo
University of Bristol
United Kingdom
University of Bristol
United Kingdom
Causes and benefits of respiratory sinus arrhythmia
15.45 - 16.15
15.45 - 16.15
Alona Ben-Tal
Massey University
New Zealand
Massey University
New Zealand
Topic:
Day: